Previous Close | 5.50 |
Open | 5.35 |
Bid | 0.12 x 5000 |
Ask | 0.50 x 5000 |
Day's Range | 5.50 - 5.50 |
52 Week Range | 0.65 - 7.73 |
Volume | |
Avg. Volume | 524 |
Market Cap | 15.952M |
Beta (5Y Monthly) | 0.55 |
PE Ratio (TTM) | 18.97 |
EPS (TTM) | 0.29 |
Earnings Date | Mar 29, 2022 - Apr 04, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jul 20, 2015 |
1y Target Est | N/A |
- First Quarter 2022 Revenue Increased Over 75% Year-over-Year - - Sustained Census and Operational Improvements Drive Strategic Progress Through the First Half of 2022 - - Christine Lucus Appointed as Interim Chief Financial Officer - - Appointment of David Furstenberg to Board of Directors Establishes Standing Audit Committee and Strengthens Corporate Governance Structure - Greenwood Village, Colorado, July 11, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Comp
Greenwood Village, CO, April 26, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") announced that it will be postponing its scheduled conference call on Tuesday, April 26, 2022 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2021. The postponement is due to additional time needed to finalize the audit of its 2021 financial statements. The Company remains committed to reporting its fourth quarter and f
Greenwood Village, CO, April 20, 2022 (GLOBE NEWSWIRE) -- Selectis Health, Inc. (OTC: GBCS) ("Selectis" or the "Company") will hold a conference call on Tuesday, April 26, 2022 at 4:30 p.m. ET to discuss its financial results for the fourth quarter and full year ended December 31, 2021. The Company will report its results in a press release prior to the conference call. Date: Tuesday, April 26, 2022Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)Toll-free dial-in number: 1-877-704-4453Inter